The global demand for COVID-19 Antibody Detection Kit Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
A COVID-19 antibody detection kit is a device that can detect the IgG and IgM antibodies in individual blood or plasma with up to 98.5% accuracy. A drop of blood is needed from a finger prick for detection, and results are delivered in a few minutes. This kit is used to measure the body's immune response and determine whether a person's body ever produced an antibody response to SARS-CoV-2 infection, thus indicating both past exposures to an infection by a novel coronavirus. These detection kits are based on the principle of immuno-chromatography. Testing people for antibodies would greatly help in managing vaccination drives if a cure is developed for COVID-19.
Massively rising cases of coronavirus worldwide will be the main driving factor for the growth of this market. An increase in government approvals for novel antibody test kits will boost market growth. These detection kits benefits include high-quality results, ease of operation, suitable for individual or a group of samples testing, and the ability to store at room temperature for a more extended period will benefit this market's growth. The demand for these kits, both for diagnosis and population surveillance, will be a market booster. The few factors that can hamper this market's development are limited availability of kits and skilled professional's shortage.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of COVID-19 antibody detection kit.
The entire COVID-19 Antibody Detection Kit market has been sub-categorized into type, application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Rapid Diagnostic Test (RDT)
- Enzyme Linked Immunosorbent Assay (ELISA)
- Neutralization Assay
- Scientific Research
This section covers regional segmentation which accentuates on current and future demand for COVID-19 antibody detection kit market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global COVID-19 Antibody Detection Kit Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the COVID-19 antibody detection kit market include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.